TG Therapeutics, Inc. (TGTX)
56.05
+1.78
(+3.28%)
USD |
NASDAQ |
Aug 24, 16:00
56.45
+0.40
(+0.71%)
After-Hours: 19:58
TG Therapeutics Max Drawdown (5Y) : 93.19% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 93.19% |
| June 30, 2026 | 93.19% |
| May 31, 2026 | 93.19% |
| April 30, 2026 | 93.19% |
| March 31, 2026 | 93.19% |
| February 28, 2026 | 93.19% |
| January 31, 2026 | 93.19% |
| December 31, 2025 | 93.19% |
| November 30, 2025 | 93.19% |
| October 31, 2025 | 93.19% |
| September 30, 2025 | 93.19% |
| August 31, 2025 | 93.19% |
| July 31, 2025 | 93.19% |
| June 30, 2025 | 93.19% |
| May 31, 2025 | 93.19% |
| April 30, 2025 | 93.19% |
| March 31, 2025 | 93.19% |
| February 28, 2025 | 93.19% |
| January 31, 2025 | 93.19% |
| December 31, 2024 | 93.19% |
| November 30, 2024 | 93.19% |
| October 31, 2024 | 93.19% |
| September 30, 2024 | 93.19% |
| August 31, 2024 | 93.19% |
| July 31, 2024 | 93.19% |
| Date | Value |
|---|---|
| June 30, 2024 | 93.19% |
| May 31, 2024 | 93.19% |
| April 30, 2024 | 93.19% |
| March 31, 2024 | 93.19% |
| February 29, 2024 | 93.19% |
| January 31, 2024 | 93.19% |
| December 31, 2023 | 93.19% |
| November 30, 2023 | 93.19% |
| October 31, 2023 | 93.19% |
| September 30, 2023 | 93.19% |
| August 31, 2023 | 93.19% |
| July 31, 2023 | 93.19% |
| June 30, 2023 | 93.19% |
| May 31, 2023 | 93.19% |
| April 30, 2023 | 93.19% |
| March 31, 2023 | 93.19% |
| February 28, 2023 | 93.19% |
| January 31, 2023 | 93.19% |
| December 31, 2022 | 93.19% |
| November 30, 2022 | 93.19% |
| October 31, 2022 | 93.19% |
| September 30, 2022 | 93.19% |
| August 31, 2022 | 93.19% |
| July 31, 2022 | 93.19% |
| June 30, 2022 | 93.19% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Krystal Biotech, Inc. | 53.42% |
| MAIA Biotechnology, Inc. | -- |
| Vericel Corp. | 73.97% |
| Incyte Corp. | 58.51% |
| Regeneron Pharmaceuticals, Inc. | 59.69% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -10.33 |
| Beta (5Y) | 1.622 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 94.29% |
| Historical Sharpe Ratio (5Y) | 0.0488 |
| Historical Sortino (5Y) | 0.0938 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.33% |